BRIEF—Chinese regulator meets with World Health Orgnaization

The China Food and Drug Administration says that Li Li, deputy commissioner of the National Drug Administration of China (CNDA), met with the World Health Organization’s China representative Gauden Galea last week.

Li Li “introduced the progress of the CNDA's institutional reform,” and “said that China would further improve its drug regulatory system and deepen the reform of the examination and approval system.”

The commissioner also signalled the agency’s intention to “strengthen the construction of professional reviewers and inspectors,” and “actively promote smart supervision and transparent supervision.”